Scholar Rock Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep SRRK

Logo korporat perusahaan Scholar Rock (SRRK)

Anticipation of new drug approvals and the commercial launch of muscle atrophy therapy define the current development stage of Scholar Rock (SRRK). The expected EPS growth for the coming year on GURU.Markets shows that this parameter reaches 18.20. This is supported by high scientific potential in cell signaling and the diversification of R&D between oncology and fibrotic pathologies.

Scholar Rock Corp (SRRK): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 16.11.2026

Ringkesan rincian data analitis Scholar Rock Corp (SRRK)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:SRRK, scholarrock.com
Produk dadi Scholar Rock, Inc.

The indicator aggregates daily adjustments to expected earnings, smoothing out infrequent reports to identify hidden drawdowns in fundamental valuation. The sideways trend on this chart of consensus EPS growth estimates for next year signals stagnating expectations, which is critical for Scholar Rock (SRRK) as the commercial success of its myopathy treatment ecosystem depends entirely on strict FDA approval timelines.

Analisis pesaing

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jazz Pharmaceuticals|CYTK: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PTC Bio (PTCT)|CNTA - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep dyne-tx.com DYN|Edgewise Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|RAPP - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Alumis Inc.|ZVRA: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Contineum Pharma CTNM|Prakiraan wutah bathi saben saham kanggo taun ngarep LRMR|Prakiraan wutah bathi resik saben saham ing taun ngarep Capricor Therapeutics CAPR|Prakiraan wutah bathi kanggo taun ngarep TRDA|Prakiraan wutah bathi saben saham kanggo taun ngarep Channel Therapeutics PTHS|Prakiraan wutah bathi kanggo taun ngarep MNOV (MediciNova)|Dinamika bathi saben saham sing diarepake ing taun ngarep SER|BTAI - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|promisneurosciences.com (PMN) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Apimeds (APUS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AEON|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NLS Pharma|Prakiraan wutah bathi resik saben saham ing taun ngarep bionomics.com.au BNOX|Prakiraan wutah bathi kanggo taun ngarep HUGE|RETA (Reata Pharma) - Dinamika bathi saben saham sing diarepake ing taun ngarep